In addition, our previous research proved a frequent (47.5%) loss of heterozygosity (LOH) located in intron 1 (microsatellite marker D16S518) of the WWOX gene, together with positive correlation between the levels of WWOX and CCND1 mRNA in bladder cancer patients [7]. The gene discussed is WWOX; the disease is urinary bladder cancer.